Aurora Cannabis Inc has shown modest gains this week amid solid revenue growth and strategic initiatives.
Aurora Cannabis Inc (ACB.TO) has experienced a slight uptick in its stock price, closing at C$3.77, reflecting a 0.53% increase on the day and a 3.85% rise over the week. This week's performance follows recent announcements about the company's financial results and strategic plans.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Aurora Cannabis Inc
ACB.TO
ACB.TO
Aurora Cannabis Inc
WealthAwesomeMarket cap
$233.52M
52W high
$9.33
52W low
$3.59
1W change
+1.89%
Beta
1.35
Analyst Price Targets
Based on analyst covering ACB
Wall Street analysts forecast ACB stock price to rise 54.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.84
+54.9% Upside
Current Price
C$3.77
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ACB's historical volatility
30-Day Vol
32.6%
Annualized
90-Day Vol
48.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$3.15
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$3.55 | C$3.17 – C$3.97 |
| 60 trading days | C$3.35 | C$2.86 – C$3.92 |
| 90 trading days | C$3.15 | C$2.60 – C$3.83 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors may find Aurora's recent revenue growth encouraging, though the stock's performance remains volatile with a significant year-to-date decline. The company's strategic initiatives, including new product launches and support for veterans, could influence future performance.
Aurora Reports 37% Year-Over-Year Revenue Growth
The company achieved a remarkable 37% increase in global medical cannabis net revenue, reaching C$64.8 million, alongside an 85% rise in international revenue to C$37.1 million.
Bull case
Aurora's increase in medical cannabis revenue and positive cash flow indicate strong operational performance. The company is debt-free and has cash reserves, which provide a buffer for future growth initiatives.
Bear case
Despite the recent revenue increases, Aurora's stock has seen significant declines this year, and its profit margins remain negative. The stock's beta of 1.35 suggests higher volatility, which could pose risks for investors.
Recent Performance
Aurora Cannabis Inc's stock closed at C$3.77, reflecting a 0.53% increase on the day and a 3.85% rise for the week. However, the stock is down 7.35% over the past month and has experienced a significant 36.36% decline year-to-date. This performance highlights the stock's volatility, which may concern potential investors.
Company News and Catalysts
Aurora recently announced impressive fiscal results, reporting a 37% year-over-year increase in global medical cannabis net revenue to C$64.8 million. The company also noted a substantial 200% growth in adjusted EBITDA to C$10.8 million, alongside positive free cash flow of C$9.2 million. These figures suggest an operational turnaround, bolstered by strategic initiatives such as product launches and support for veterans across Canada.
Technical Picture
The technical indicators for Aurora Cannabis show that the stock is currently trading below both its 50-day moving average of C$4.27 and its 200-day moving average of C$5.34, indicating a bearish trend. The stock has a 52-week range of C$3.59 – C$9.33, with current prices near the lower end of this range. With a beta of 1.35, the stock exhibits higher volatility compared to the broader market. Volume for the latest trading session was 247,126 shares, which is 48% of the 20-day average volume of 322,804 shares.
Advertisement
Wealth Awesome Newsroom
The Wealth Awesome Newsroom delivers timely Canadian market updates, earnings, dividends, and stock movers for DIY investors. Coverage is reviewed against public filings and market data feeds.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
